Armstrong Pharmaceuticals Inc

AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The company has two commercial products, Feridex I.V. and GastroMARK, both of which are imaging agents that are approved and marketed in the United States, Europe and other countries. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging (MRI) to aid in the differentiation of cancerous from normal lymph nodes. AMAG Pharmaceuticals corporate and executive offices are located in Cambridge, Mass.

ChemGenes Corporation, a biotechnology company, recently relocated to a state of the art facility in Wilmington, Massachusetts. We have consistently been a strong partner to researchers engaged in the field of DNA/RNA synthesis for 23 years. By starting out as a supplier of 'Ultra Pure Products' and then also by becoming an active Contract Researcher, ChemGenes Corporation has achieved unparalleled expertise in the field of DNA/RNA synthesis. Thus, all of us at ChemGenes have the opportunity and great pleasure to serve a vast number of scientists in the US and all over the world.ChemGenes' product lines include phosphoramidites for RNA and DNA synthesis, Antisense phosphoramidites, modified bases for DNA, as well as RNA modification. In addition, we produce a variety of modified phosphoramidites for the introduction of chromophores and ligands. The availability of prepacked disposable columns of various pore sizes, loadings, low volume columns, ancillary reagents in configurations suitable for each synthesizer, and DNA purification cartridges is another way ChemGenes meets its customers needs.A large variety of Reagents for the synthesis of DNA/RNA are also available, which include many natural and modified nucleoside bases, tetrazole, 5-thioethyltetrazole, DMT-chloride, DMT protected deoxy and ribo nucleosides, 2'-O-methyl and 2'-O-propargyl nucleosides, silyl protected ribonucleosides, several types of phosphorylating reagents, and many more.

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website